An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy. (2022)
Attributed to:
Sulphides - Economically important geochemical messengers from the mantle
funded by
NERC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2022.1022598
PubMed Identifier: 36505399
Publication URI: http://europepmc.org/abstract/MED/36505399
Type: Journal Article/Review
Volume: 13
Parent Publication: Frontiers in immunology
ISSN: 1664-3224